Beta Bionics has announced that it has partnered with Abbott (NYSE:ABT) to integrate the company’s CGM with its automated insulin delivery system....
Vous n'êtes pas connecté
Senseonics and its commercial partner Ascensia Diabetes Care have received clearance from the Food and Drug Administration for the first implantable glucose sensor that can be worn for one year, doubling the wear time of Senseonics’ current sensor. The continuous glucose monitor (CGM), called Eversense 365, is implanted just under the skin. A removable transmitter […]
Beta Bionics has announced that it has partnered with Abbott (NYSE:ABT) to integrate the company’s CGM with its automated insulin delivery system....
HuidaGene Therapeutics (HuidaGene), a global clinical─stage biotechnology company developing genome medicines, announced that the US FDA has cleared...
Botanix's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating. ...
The number of American adults with diabetes is growing rapidly, with nearly 16%—or about one in six adults—now affected, according to the latest...
SOUTH SAN FRANCISCO, Calif, Nov. 15, 2024 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative...
THURSDAY, Nov. 7, 2024 -- More than a year after its advisory panel unanimously declared the drug phenylephrine to be useless against nasal...